Involvement of activating NK cell receptors and their modulation in pathogen immunity

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  De Maria, Andrea ^a,c   Marras, Francesco ^a   Bozzano, Federica ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD16 ANTIGEN; CD27 ANTIGEN; CD56 ANTIGEN; ETHAMBUTOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; ISONIAZID; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; PYRAZINAMIDE; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS HEMAGGLUTININ;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; B LYMPHOCYTE ACTIVATION; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DEGRANULATION; DENDRITIC CELL; DISEASE COURSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; IMMUNOREGULATION; INFLUENZA VIRUS; LUNG TUBERCULOSIS; LYMPHOCYTE PROLIFERATION; MACACA FASCICULARIS; MACACA MULATTA; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REVIEW; SENDAI VIRUS; SIGNAL TRANSDUCTION; VIRAL CLEARANCE; VIROTHERAPY; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PATHOGENESIS; VIRUS VIRULENCE; ANIMAL; DISEASE MODEL; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MACACA; TUBERCULOSIS; VIROLOGY;

HEPATITIS C VIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MACACA; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, NATURAL KILLER CELL; TUBERCULOSIS;

EID: 80053505409     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/152430     Document Type: Review

References (126)

1. Trinchieri G., Biology of natural killer cells Advances in Immunology 1989 47 187 376 (Pubitemid 20010960)
2. Moretta L., Biassoni R., Bottino C., Mingari M. C., Moretta A., Human NK-cell receptors Immunology Today 2000 21 9 420 422
3. Vivier E., Raulet D. H., Moretta A., Innate or adaptive immunity? The example of natural killer cells Science 2011 331 6013 44 49
4. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C., Moretta L., Moretta A., p46, a novel natural killer cell-specific surface molecule that mediates cell activation Journal of Experimental Medicine 1997 186 7 1129 1136 (Pubitemid 27441156)
5. Pessino A., Sivori S., Bottino C., Malaspina A., Morelli L., Moretta L., Biassoni R., Moretta A., Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity Journal of Experimental Medicine 1998 188 5 953 960 (Pubitemid 28433421)
6. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L., Moretta A., NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis Journal of Experimental Medicine 1998 187 12 2065 2072 (Pubitemid 28285576)
7. Cantoni C., Bottino C., Vitale M., Pessino A., Augugliaro R., Malaspina A., Parolini S., Moretta L., Moretta A., Biassoni R., NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily Journal of Experimental Medicine 1999 189 5 787 795 (Pubitemid 29189683)
8. Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L., Marcenaro E., Accame L., Malaspina A., Biassoni R., Bottino C., Moretta L., Moretta A., Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells Journal of Experimental Medicine 1999 190 10 1505 1516
9. Fuchs A., Cella M., Kondo T., Colonna M., Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44 Blood 2005 106 6 2076 2082 (Pubitemid 41291722)
10. Bonaccorsi I., Cantoni C., Carrega P., Oliveri D., Lui G., Conte R., Navarra M., Cavaliere R., Traggiai E., Gattorno M., Martini A., Mingari M. C., Moretta A., Ferlazzo G., The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFN production PLoS ONE 2010 5 11
11. Tang Q., Grzywacz B., Wang H., Kataria N., Cao Q., Wagner J. E., Blazar B. R., Miller J. S., Verneris M. R., Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional Journal of Immunology 2008 181 7 4507 4515
12. Biassoni R., Cantoni C., Pende D., Sivori S., Parolini S., Vitale M., Bottino C., Moretta A., Human natural killer cell receptors and co-receptors Immunological Reviews 2001 181 203 214 (Pubitemid 32703408)
13. Sivori S., Parolini S., Falco M., Marcenaro E., Biassoni R., Bottino C., Moretta L., Moretta A., 2B4 functions as a co-receptor in human NK cell activation European Journal of Immunology 2000 30 3 787 793 (Pubitemid 30216250)
14. Byrd A., Hoffman S. C., Jarahian M., Momburg F., Watzl C., Expression analysis of the ligands for the natural killer cell receptors NKp30 and NKp44 PLoS ONE 2007 2 12
15. Sivori S., Parolini S., Marcenaro E., Castriconi R., Pende D., Millo R., Moretta A., Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines Journal of Neuroimmunology 2000 107 2 220 225 (Pubitemid 30347431)
16. Costello R. T., Sivori S., Marcenaro E., Lafage-Pochitaloff M., Mozziconacci M. J., Reviron D., Gastaut J. A., Pende D., Olive D., Moretta A., Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia Blood 2002 99 10 3661 3667 (Pubitemid 34534536)
17. Pende D., Rivera P., Marcenaro S., Chang C. C., Biassoni R., Conte R., Kubin M., Cosman D., Ferrone S., Moretta L., Moretta A., Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes Cancer Research 2002 62 21 6178 6186
18. Brandt C. S., Baratin M., Yi E. C., Kennedy J., Gao Z., Fox B., Haldeman B., Ostrander C. D., Kaifu T., Chabannon C., Moretta A., West R., Xu W., Vivier E., Levin S. D., The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans Journal of Experimental Medicine 2009 206 7 1495 1503
19. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T. I., Bushkin Y., Davis D. M., Strominger J. L., Yewdell J. W., Porgador A., Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells Nature 2001 409 6823 1055 1060 (Pubitemid 32204059)
20. Hershkovitz O., Rosental B., Rosenberg L. A., Navarro-Sanchez M. E., Jivov S., Zilka A., Gershoni-Yahalom O., Brient-Litzler E., Bedouelle H., Ho J. W., Campbell K. S., Rager-Zisman B., Despres P., Porgador A., NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells Journal of Immunology 2009 183 4 2610 2621
21. Wu J., Song Y., Bakker A. B. H., Bauer S., Spies T., Lanier L. L., Phillips J. H., An activating immunoreceptor complex formed by NKG2D and DAP10 Science 1999 285 5428 730 732
22. Cerwenka A., Lanier L. L., Ligands for natural killer cell receptors: redundancy or specificity Immunological Reviews 2001 181 158 169 (Pubitemid 32703404)
23. Diefenbach A., Jensen E. R., Jamieson A. M., Raulet D. H., Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity Nature 2001 413 6852 165 171 (Pubitemid 32867877)
24. Groh V., Rhinehart R., Randolph-Habecker J., Topp M., Riddell S., Spies T., Costimulation of CD8alphabeta T cell by NKG2D via engagement by MIC induced on virus-infected cells Nature Immunology 2001 2 3 255 260 (Pubitemid 33706003)
25. Sutherland C. L., Chalupny N. J., Cosman D., The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions Immunological Reviews 2001 181 185 192 (Pubitemid 32703406)
26. Ward J., Bonaparte M., Sacks J., Guterman J., Fogli M., Mavilio D., Barker E., HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts Blood 2007 110 4 1207 1214 (Pubitemid 47281418)
27. Parolini S., Bottino C., Falco M., Augugliaro R., Giliani S., Franceschini R., Ochs H. D., Wolf H., Bonnefoy J. Y., Biassoni R., Moretta L., Moretta A., X-linked lymphoproliferative disease Journal of Experimental Medicine 2000 192 3 337 346
28. Bottino C., Falco M., Parolini S., Marcenaro E., Augugliaro R., Sivori S., Landi E., Biassoni R., Notarangelo L. D., Moretta L., Moretta A., NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease Journal of Experimental Medicine 2001 194 3 235 246 (Pubitemid 32730798)
29. Vitale M., Falco M., Castriconi R., Petrone A. L., Cerasoli D. M., Scott P., Caton A. J., Identification of NKp80, a novel triggering molecule expressed by human NK cells European Journal of Immunology 2001 31 1 233 242 (Pubitemid 32096014)
30. Kuttruff S., Koch S., Kelp A., Pawelec G., Rammensee H. G., Steinle A., NKp80 defines and stimulates a reactive subset of CD8 T cells Blood 2009 113 2 358 369
31. Welte S., Kuttruff S., Waldhauer I., Steinle A., Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction Nature Immunology 2006 7 12 1334 1342 (Pubitemid 46111255)
32. Bottino C., Castriconi R., Pende D., Rivera P., Nanni M., Carnemolla B., Cantoni C., Grassi J., Marcenaro S., Reymond N., Vitale M., Moretta L., Lopez M., Moretta A., Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule Journal of Experimental Medicine 2003 198 4 557 567 (Pubitemid 37040390)
33. Orange J. S., Wang B., Terhorst C., Biron C. A., Requirement for natural killer cell-produced interferon in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration Journal of Experimental Medicine 1995 182 4 1045 1056
34. Tay C. H., Szomolanyi-Tsuda E., Welsh R. M., Control of infections by NK cells Current Topics in Microbiology and Immunology 1998 230 193 220 (Pubitemid 28183724)
35. Doolan D. L., Hoffman S. L., IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the plasmodium yoelii model Journal of Immunology 1999 163 2 884 892 (Pubitemid 29328098)
36. Ma L. L., Neely G. G., Epelman S., Krensky A. M., Mody C. H., NK cells use perforin rather than granulysin for anticryptococcal activity Journal of Immunology 2004 173 5 3357 3365 (Pubitemid 39142045)
37. Arase H., Mocarski E. S., Campbell A. E., Hill A. B., Lanier L. L., Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors Science 2002 296 5571 1323 1326 (Pubitemid 34522789)
38. Lanier L. L., On guardActivating NK cell receptors Nature Immunology 2001 2 1 23 27
39. Khakoo S. I., Thio C. L., Martin M. P., Brooks C. R., Gao X., Astemborski J., Cheng J., Goedert J. J., Vlahov D., Hilgartner M., Cox S., Little A. M., Alexander G. J., Cramp M. E., O'Brien S. J., Rosenberg W. M. C., Thomas D. L., Carrington M., HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection Science 2004 305 5685 872 874 (Pubitemid 39038423)
40. Arnon T. I., Lev M., Katz G., Chernobrov Y., Porgador A., Mandelboim O., Recognition of viral hemagglutinins by NKp44 but not by NKp30 European Journal of Immunology 2001 31 9 2680 2689 (Pubitemid 32898735)
41. Gazit R., Gruda R., Elboim M., Arnon T. I., Katz G., Achdout H., Hanna J., Qimron U., Landau G., Greenbaum E., Zakay-Rones Z., Porgador A., Mandelboim O., Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1 Nature Immunology 2006 7 5 517 523
42. Chisholm S. E., Reyburn H. T., Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors Journal of Virology 2006 80 5 2225 2233 (Pubitemid 43271529)
43. Esin S., Batoni G., Counoupas C., Stringaro A., Brancatisano F. L., Colone M., Maisetta G., Florio W., Arancia G., Campa M., Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria Infection and Immunity 2008 76 4 1719 1727 (Pubitemid 351562017)
44. Vieillard V., Strominger J. L., Debré P., NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand Proceedings of the National Academy of Sciences of the United States of America 2005 102 31 10981 10986 (Pubitemid 41105979)
45. Vieillard V., Costagliola D., Simon A., Debré P., Study FALTA. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection AIDS 2006 20 14 1795 1804 (Pubitemid 44358897)
46. Fausther-Bovendo H., Vieillard V., Sagan S., Bismuth G., Debré P., Hiv gp41 engages gc1qr on cd4+ t cells to induce the expression of an nk ligand through the pip3/h2o2 pathway PLoS Pathogens 2010 6 7 1 14
47. Bauer S., Groh V., Wu J., Steinle A., Phillips J. H., Lanier L. L., Spies T., Activation of NK cells and T cells by NKG2D, a receptor for stress- inducible MICA Science 1999 285 5428 727 729
48. Kubin M., Cassiano L., Chalupny J., Chin W., Cosman D., Fanslow W., Mllberg J., Rousseau A. M., Ulrich D., Armitage R., ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells European Journal of Immunology 2001 31 5 1428 1437 (Pubitemid 32454690)
49. Cosman D., Mllberg J., Sutherland C. L., Chin W., Armitage R., Fanslow W., Kubin M., Chalupny N. J., ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor Immunity 2001 14 2 123 133 (Pubitemid 32206515)
50. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., Spies T., Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium Proceedings of the National Academy of Sciences of the United States of America 1996 93 22 12445 12450 (Pubitemid 26367163)
51. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K. H., Spies T., Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB Proceedings of the National Academy of Sciences of the United States of America 1999 96 12 6879 6884 (Pubitemid 29274978)
52. Fang M., Lanier L. L., Sigal L. J., A role for NKG2D in NK cell-mediated resistance to poxvirus disease PLoS Pathogens 2008 4 2
53. Campbell J. A., Trossman D. S., Yokoyama W. M., Carayannopoulos L. N., Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D Journal of Experimental Medicine 2007 204 6 1311 1317 (Pubitemid 46919869)
54. Costa P., Sivori S., Bozzano F., Martini I., Moretta A., Moretta L., De Maria A., IFN- -mediated increase in cytolytic activity of maturing NK cell upon exposure to HSV-infected myelomonocytes European Journal of Immunology 2009 39 1 147 158
55. Cerboni C., Neri F., Casartelli N., Zingoni A., Cosman D., Rossi P., Santoni A., Doria M., Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity Journal of General Virology 2007 88 1 242 250 (Pubitemid 46085135)
56. Thomas M., Boname J. M., Field S., Nejentsev S., Salio M., Cerundolo V., Wills M., Lehner P. J., Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity Proceedings of the National Academy of Sciences of the United States of America 2008 105 5 1656 1661 (Pubitemid 351346570)
57. Dunn C., Chalupny N. J., Sutherland C. L., Dosch S., Sivakumar P. V., Johnson D. C., Cosman D., Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity Journal of Experimental Medicine 2003 197 11 1427 1439 (Pubitemid 36682542)
58. Wen C., He X., Ma H., Hou N., Wei C., Song T., Zhang Y., Sun L., Ma Q., Zhong H., Hepatitis C virus infection downregulates the ligands of the activating receptor NKG2D Cellular amp; Molecular Immunology 2008 5 6 475 478
59. Kubin M. Z., Parshley D. L., Din W., Waugh J. Y., Davis-Smith T., Smith C. A., Macduff B. M., Armitage R. J., Chin W., Cassiano L., Borges L., Petersen M., Trinchieri G., Goodwin R. G., Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48 European Journal of Immunology 1999 29 11 3466 3477 (Pubitemid 29527794)
60. Nakajima H., Cella M., Langen H., Friedlein A., Colonna M., Activating interactions in human NK cell recognition: the role of 2B4-CD48 European Journal of Immunology 1999 29 5 1676 1683 (Pubitemid 29224473)
61. Carrington M., O'Brien S. J., The Influence of HLA genotype on AIDS Annual Review of Medicine 2003 54 535 551 (Pubitemid 37386411)
62. Newell M. L., Dunn D., De Maria A., Ferrazin A., De Rossi A., Giaquinto C., Levy J., Alimenti A., Ehrnst A., Bohlin A. B., Ljung R., Peckham C., Detection of virus in vertically exposed HIV-antibody-negative children The Lancet 1996 347 8996 213 215 (Pubitemid 26035244)
63. Rowland-Jones S. L., Nixon D. F., Aldhous M. C., Gotch F., Ariyoshi K., Hallam N., Kroll J. S., Froebel K., McMichael A., HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infants The Lancet 1993 341 8849 860 861 (Pubitemid 23094512)
64. De Maria A., Cirillo C., Moretta L., Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1- infected mothers Journal of Infectious Diseases 1994 170 5 1296 1299
65. Kaul R., Plummer F., Clerici M., Bomsel M., Lopalco L., Broliden K., Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection AIDS 2001 15 3 431 432 (Pubitemid 32163839)
66. Poli G., Introna M., Zanaboni F., Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome Clinical and Experimental Immunology 1985 62 1 128 135 (Pubitemid 15229738)
67. De Maria A., Fogli M., Costa P., Murdaca G., Puppo F., Mavilio D., Moretta A., Moretta L., The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44) European Journal of Immunology 2003 33 9 2410 2418 (Pubitemid 37138973)
68. Alter G., Teigen N., Davis B. T., Addo M. M., Suscovich T. J., Waring M. T., Streeck H., Johnston M. N., Staller K. D., Tauheed Zaman M., Yu X. G., Lichterfeld M., Basgoz N., Rosenberg E. S., Altfeld M., Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection Blood 2005 106 10 3366 3369 (Pubitemid 41609166)
69. Brenner B. G., Dascal A., Margolese R. G., Wainberg M. A., Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases Journal of Leukocyte Biology 1989 46 1 75 83 (Pubitemid 19176602)
70. Lucia M. B., Froio N., Tacconelli E., Tumbarello M., Rutella S., Rumi C., Cauda R., CD16+CD56+CD8+ natural killer (NK) cells are decreased during HIV infection European Journal of Histochemistry 1997 41 supplement 2 197 198
71. Goodier M. R., Imami N., Moyle G., Gazzard B., Gotch F., Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone Clinical and Experimental Immunology 2003 134 3 470 476 (Pubitemid 37542087)
72. Mavilio D., Lombardo G., Benjamin J., Kim D., Follman D., Marcenaro E., O'Shea M. A., Kinter A., Kovacs C., Moretta A., Fauci A. S., Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals Proceedings of the National Academy of Sciences of the United States of America 2005 102 8 2886 2891 (Pubitemid 40299886)
73. Fogli M., Costa P., Murdaca G., Setti M., Mingari M. C., Moretta L., Moretta A., De Maria A., Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients European Journal of Immunology 2004 34 8 2313 2321 (Pubitemid 39256113)
74. Mavilio D., Lombardo G., Kinter A., Fogli M., La Sala A., Ortolano S., Farschi A., Follmann D., Gregg R., Kovacs C., Marcenaro E., Pende D., Moretta A., Fauci A. S., Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection Journal of Experimental Medicine 2006 203 10 2339 2350 (Pubitemid 44498368)
75. Ferlazzo G., Morandi B., D'Agostino A., Meazza R., Melioli G., Moretta A., Moretta L., The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells European Journal of Immunology 2003 33 2 306 313 (Pubitemid 36267594)
76. Ferlazzo G., Tsang M., Moretta L., Melioli G., Steinman R., Mnz C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells Journal of Experimental Medicine 2002 195 3 343 351 (Pubitemid 34461492)
77. Pende D., Castriconi R., Romagnani P., Spaggiari G. M., Marcenaro S., Dondero A., Lazzeri E., Lasagni L., Martini S., Rivera P., Capobianco A., Moretta L., Moretta A., Bottino C., Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction Blood 2006 107 5 2030 2036 (Pubitemid 43289387)
78. Spaggiari G. M., Carosio R., Pende D., Marcenaro S., Rivera P., Zocchi M. R., Moretta L., Poggi A., NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46 European Journal of Immunology 2001 31 6 1656 1665 (Pubitemid 32547327)
79. Vitale M., Della Chiesa M., Carlomagno S., Pende D., Aric M., Moretta L., Moretta A., NK-dependent DC maturation is mediated by TNF-a and IFN-g released upon engagement of the NKp30 triggering receptor Blood 2005 106 2 566 571 (Pubitemid 40981252)
80. Steinman R. M., Hawiger D., Nussenzweig M. C., Tolerogenic dendritic cells Annual Review of Immunology 2003 21 685 711 (Pubitemid 37174545)
81. Mantegani P., Tambussi G., Galli L., Din C. T., Lazzarin A., Fortis C., Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56bright subset Immunology 2010 129 2 220 233
82. De Maria A., Mavilio D., Costa P., Dignetti P., Fogli M., Mingari M. C., Multiple HLA-class I-specific inhibitory NK receptor expression and IL-4/IL-5 production by CD8+ T-cell clones in HIV-1 infection Immunology Letters 2000 72 3 179 182 (Pubitemid 30398592)
83. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M. A., Marcenaro E., Bottino C., Moretta L., Moretta A., Fauci A. S., Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates Proceedings of the National Academy of Sciences of the United States of America 2003 100 25 15011 15016 (Pubitemid 37518008)
84. De Maria A., Ferraris A., Guastella M., Pilia S., Cantoni C., Polero L., Mingari M. C., Bassetti D., Fauci A. S., Moretta L., Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: Impairment of specific cytolytic functions Proceedings of the National Academy of Sciences of the United States of America 1997 94 19 10285 10288 (Pubitemid 27407033)
85. Valentin A., Rosati M., Patenaude D. J., Hatzakis A., Kostrikis L. G., Lazanas M., Wyvill K. M., Yarchoan R., Pavlakis G. N., Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy Proceedings of the National Academy of Sciences of the United States of America 2002 99 10 7015 7020 (Pubitemid 34526249)
86. Bernstein H. B., Wang G., Plasterer M. C., Zack J. A., Ramasastry P., Mumenthaler S. M., Kitchen C. M. R., CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function Virology 2009 387 1 59 66
87. Milush J. M., Long B. R., Snyder-Cappione J. E., Cappione A. J., York V. A., Ndhlovu L. C., Lanier L. L., Michalsson J., Nixon D. F., Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4 Blood 2009 114 23 4823 4831
88. Azzoni L., Papasavvas E., Chehimi J., Kostman J. R., Mounzer K., Ondercin J., Perussia B., Montaner L. J., Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity Journal of Immunology 2002 168 11 5764 5770 (Pubitemid 34556161)
89. Bozzano F., Nasi M., Bertoncelli L., Nemes E., Prati F., Marras F., Mussini C., Moretta L., Cossarizza A., de Maria A., NK-cell phenotype at interruption underlies widely divergent duration of CD4+- guided antiretroviral treatment interruption International Immunology 2011 23 2 109 118
90. Alter G., Martin M. P., Teigen N., Carr W. H., Suscovich T. J., Schneidewind A., Streeck H., Waring M., Meier A., Brander C., Lifson J. D., Allen T. M., Carrington M., Altfeld M., Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes Journal of Experimental Medicine 2007 204 12 3027 3036 (Pubitemid 350179568)
91. Martin M. P., Gao X., Lee J. H., Nelson G. W., Detels R., Goedert J. J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., Wilson M., O'Brien S. J., Carrington M., Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS Nature Genetics 2002 31 4 429 434 (Pubitemid 35154456)
92. De Maria A., Moretta L., NK cell function in HIV-1 infection Current HIV Research 2008 6 5 433 440
93. De Maria A., Biassoni R., Fogli M., Rizzi M., Cantoni C., Costa P., Conte R., Mavilio D., Ensoli B., Cafaro A., Moretta A., Moretta L., Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells European Journal of Immunology 2001 31 12 3546 3556 (Pubitemid 34030967)
94. Biassoni R., Fogli M., Cantoni C., Costa P., Conte R., Koopman G., Cafaro A., Ensoli B., Moretta A., Moretta L., De Maria A., Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection Journal of Immunology 2005 174 9 5695 5705 (Pubitemid 40593212)
95. De Maria A., Ugolotti E., Rutjens E., Mazza S., Radic L., Faravelli A., Koopman G., Di Marco E., Costa P., Ensoli B., Cafaro A., Mingari M. C., Moretta L., Heeney J., Biassoni R., NKp44 expression, phylogenesis and function in non-human primate NK cells International Immunology 2009 21 3 245 255
96. Rutjens E., Mazza S., Biassoni R., Koopman G., Radic L., Fogli M., Costa P., Mingari M. C., Moretta L., Heeney J., De Maria A., Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals Journal of Immunology 2007 178 3 1702 1712 (Pubitemid 46154642)
97. Corado J., Toro F., Rivera H., Bianco N. E., Deibis L., De Sanctis J. B., Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection Clinical and Experimental Immunology 1997 109 3 451 457 (Pubitemid 27402312)
98. Lassen M. G., Lukens J. R., Dolina J. S., Brown M. G., Hahn Y. S., Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state Journal of Immunology 2010 184 5 2693 2701
99. Amadei B., Urbani S., Cazaly A., Fisicaro P., Zerbini A., Ahmed P., Missale G., Ferrari C., Khakoo S. I., Activation of natural killer cells during acute infection with hepatitis C virus Gastroenterology 2010 138 4 1536 1545
100. Pelletier S., Drouin C., Bédard N., Khakoo S. I., Bruneau J., Shoukry N. H., Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses Journal of Hepatology 2010 53 5 805 816
101. Morishima C., Paschal D. M., Wang C. C., Yoshihara C. S., Wood B. L., Yeo A. E. T., Emerson S. S., Shuhart M. C., Gretch D. R., Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing Hepatology 2006 43 3 573 580
102. Bonorino P., Ramzan M., Camous X., Dufeu-Duchesne T., Thélu M. A., Sturm N., Dariz A., Guillermet C., Pernollet M., Zarski J. P., Marche P. N., Leroy V., Jouvin-Marche E., Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C Journal of Hepatology 2009 51 3 458 467
103. Meier U. C., Owen R. E., Taylor E., Worth A., Naoumov N., Willberg C., Tang K., Newton P., Pellegrino P., Williams I., Klenerman P., Borrow P., Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections Journal of Virology 2005 79 19 12365 12374 (Pubitemid 41346098)
104. Oliviero B., Varchetta S., Paudice E., Michelone G., Zaramella M., Mavilio D., De Filippi F., Bruno S., Mondelli M. U., Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology 2009 137 3 1151 1160
105. Dessouki O., Kamiya Y., Nagahama H., Tanaka M., Suzu S., Sasaki Y., Okada S., Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: reversion by anti-viral treatment Biochemical and Biophysical Research Communications 2010 393 2 331 337
106. Golden-Mason L., Madrigal-Estebas L., McGrath E., Conroy M. J., Ryan E. J., Hegarty J. E., O'Farrelly C., Doherty D. G., Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure Gut 2008 57 8 1121 1128
107. Bonavita M. S., Franco A., Paroli M., Santilio I., Benvenuto R., De Petrillo G., Levrero M., Perrone A., Balsano C., Barnaba V., Normalization of depressed natural killer activity after interferon- therapy is associated with a low frequency of relapse in patients with chronic hepatitis C International Journal of Tissue Reactions 1993 15 1 11 16 (Pubitemid 23308561)
108. De Maria A., Fogli M., Mazza S., Basso M., Picciotto A., Costa P., Congia S., Mingari M. C., Moretta L., Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients European Journal of Immunology 2007 37 2 445 455 (Pubitemid 46915584)
109. Jinushi M., Takehara T., Tatsumi T., Kanto T., Miyagi T., Suzuki T., Kanazawa Y., Hiramatsu N., Hayashi N., Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection Journal of Immunology 2004 173 10 6072 6081 (Pubitemid 39487763)
110. Takehara T., Hayashi N., Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity Clinical Gastroenterology and Hepatology 2005 3 10,supplement 2 S78 S81
111. Ahlenstiel G., Titerence R. H., Koh C., Edlich B., Feld J. J., Rotman Y., Ghany M. G., Hoofnagle J. H., Liang T. J., Heller T., Rehermann B., Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner Gastroenterology 2010 138 1 325 335
112. Harrison R. J., Ettorre A., Little A. M., Khakoo S. I., Association of NKG2A with treatment for chronic hepatitis C virus infection Clinical and Experimental Immunology 2010 161 2 306 314
113. Nattermann J., Feldmann G., Ahlenstiel G., Langhans B., Sauerbruch T., Spengler U., Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C Gut 2006 55 6 869 877 (Pubitemid 43764560)
114. Bozzano F., Picciotto A., Costa P., Marras F., Fazio V., Hirsch I., Olive D., Moretta L., De Maria A., Activating NK cell receptor expression/function (NKp30,NKp46,DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment European Journal of Immunology 2011
115. Yoon J. C., Shiina M., Ahlenstiel G., Rehermann B., Natural killer cell function is intact after direct exposure to infectious hepatitis C virions Hepatology 2009 49 1 12 21
116. Crotta S., Brazzoli M., Piccioli D., Valiante N. M., Wack A., Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection Journal of Hepatology 2010 52 2 183 190
117. Knapp S., Warshow U., Hegazy D., Brackenbury L., Guha I. N., Fowell A., Little A. M., Alexander G. J., Rosenberg W. M. C., Cramp M. E., Khakoo S. I., Consistent beneficial effects of killer cell immunoglobulin-like receptor 2dl3 and group 1 human leukocyte antigen-c following exposure to hepatitis c virus Hepatology 2010 51 4 1168 1175
118. Marcenaro E., Ferranti B., Falco M., Moretta L., Moretta A., Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC International Immunology 2008 20 9 1155 1167
119. Vankayalapati R., Wizel B., Weis S. E., Safi H., Lakey D. L., Mandelboim
120. Bermudez L. E., Wu M., Young L. S., Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium Infection and Immunity 1995 63 10 4099 4104
121. Brill K. J., Li Q., Larkin R., Canaday D. H., Kaplan D. R., Boom W. H., Silver R. F., Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms Infection and Immunity 2001 69 3 1755 1765 (Pubitemid 32187635)
122. Katz P., Yeager H. Jr., Whalen G., Evans M., Swartz R. P., Roecklein J., Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes Journal of Clinical Immunology 1990 10 1 71 77 (Pubitemid 20085861)
123. Lichtner M., Rossi R., Mengoni F., Vignoli S., Colacchia B., Massetti A. P., Kamga I., Hosmalin A., Vullo V., Mastroianni C. M., Circulating dendritic cells and interferon- production in patients with tuberculosis: Correlation with clinical outcome and treatment response Clinical and Experimental Immunology 2006 143 2 329 337
124. Hinchey J., Lee S., Jeon B. Y., Basaraba R. J., Venkataswamy M. M., Chen B., Chan J., Braunstein M., Orme I. M., Derrick S. C., Morris S. L., Jacobs W. R., Porcelli S. A., Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis Journal of Clinical Investigation 2007 117 8 2279 2288 (Pubitemid 47219573)
125. Vankayalapati R., Klucar P., Wizel B., Weis S. E., Samten B., Safi H., Shams H., Barnes P. F., NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen Journal of Immunology 2004 172 1 130 137 (Pubitemid 38020464)
126. Bozzano F., Costa P., Passalacqua G., Dodi F., Ravera S., Pagano G., Canonica G. W., Moretta L., De Maria A., Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment International Immunology 2009 21 7 779 791